Copper is an essential trace element required for mitochondrial respiration, iron metabolism, antioxidant defense, connective tissue maturation, and neurotransmitter synthesis. Dietary copper insufficiency, impaired absorption, or abnormalities in copper transport can all reduce tissue copper availability. Animal models can be used to study disruption of copper homeostasis and the resulting abnormalities in metabolism and tissue function.

Keywords: copper deficiency; animal models; low-copper diet; ATP7A; copper metabolism; copper-dependent enzymes; serum copper

1 Research Basis of Copper Deficiency Models

1.1 Copper Homeostasis and Functional Copper Deficiency

After dietary copper is absorbed through the intestine, it enters the circulation and is distributed to tissues such as the liver, brain, and heart. Copper transporters such as CTR1 participate in cellular copper uptake, while copper chaperone proteins further deliver copper to copper-dependent proteins such as Cytochrome c Oxidase and Cu/Zn Superoxide Dismutase. ATP7A and ATP7B both participate in cellular copper transport and copper loading of enzymes in the secretory pathway. ATP7A mainly mediates copper export from intestinal enterocytes into the circulation and copper transport in multiple tissues, whereas ATP7B contributes to copper-protein maturation in the liver and mediates biliary excretion of excess copper.

Copper deficiency is not equivalent to a simple decrease in total tissue copper. Functionally significant copper deficiency usually manifests as reduced bioavailable copper and subsequently decreased activity of copper-dependent enzymes. Therefore, evaluation of animal models needs to consider copper content, copper-protein function, and target-tissue phenotypes simultaneously.

1.2 Major Types of Copper Deficiency Models

(1) Nutritional Copper Deficiency

Limiting dietary copper supply through a low-copper purified diet is the most direct method for modeling nutritional copper deficiency. This model is suitable for studying the relationship between chronic copper insufficiency and anemia, myocardial injury, skeletal development, and metabolic abnormalities.

(2) Genetic Impairment of Copper Utilization

Abnormalities in copper-transport-related genes such as ATP7A and SLC31A1 can impair copper absorption, cellular uptake, or tissue distribution. Such models are suitable for studying inherited disorders of copper metabolism and tissue-specific copper-dependent functions.

(3) Pharmacological Copper Depletion

Copper-binding agents such as D-Penicillamine and Tetrathiomolybdate can reduce bioavailable copper and are suitable for mechanistic validation of copper-dependent processes. Pharmacological models have characteristics such as relatively rapid onset and adjustable intervention intensity but cannot completely replace nutritional low-copper models.

Table 1 Experimental Characteristics of Major Animal Models of Copper Deficiency

2 Diet-Induced Copper Deficiency Models

2.1 Low-Copper Diet Design

(1) Control of Copper Content

Low-copper models generally use compositionally defined purified diets in which the copper content of the mineral mixture is reduced to establish the deficient group, while a control group receives an otherwise identical diet with adequate copper supply. The specific copper level needs to be determined according to animal species, age, modeling duration, and research endpoint.

(2) Control of the Basal Diet

Copper content in natural grains and complex diets varies among batches and may also be affected by the composition of other minerals. When precise control of copper intake is required, purified diets are more suitable for reducing interference from non-target copper sources and mineral interactions.

(3) Drinking Water and Housing Environment

Drinking water and housing equipment may also provide additional sources of copper. Strict low-copper models should also control drinking water, metal equipment, and other potential sources of copper contamination so that the animals’ actual copper intake remains consistent with the dietary design.

2.2 Animal Age and Intervention Duration

(1) Young Animals

Growing animals are generally more sensitive to copper restriction. Copper deficiency can simultaneously affect growth, hematopoiesis, skeletal maturation, and neurodevelopment. This model more readily produces obvious phenotypes, but copper-specific effects need to be distinguished from general growth retardation.

(2) Adult Animals

Adult models are more suitable for studying copper homeostasis in mature tissues, such as myocardial mitochondrial function, hepatic copper reserves, and antioxidant enzyme activity. Because tissues already possess certain copper reserves, establishment of stable functional copper deficiency generally requires a more adequate intervention period.

(3) Time Window

Changes in circulating copper and Ceruloplasmin may occur before obvious tissue pathology, whereas myocardial, neural, and connective-tissue damage generally develops gradually with sustained copper insufficiency. Therefore, the modeling endpoint should not be determined solely by decreased serum copper but should correspond to the research objective.

2.3 Perinatal Copper Deficiency

Perinatal models can reduce maternal copper intake during pregnancy or lactation, exposing fetuses or newborn animals to copper deficiency during rapid development. The nervous system, mitochondrial energy metabolism, and connective-tissue formation are relatively sensitive to copper supply, so developmental models are commonly used to study brain development, neurobehavior, and skeletal maturation. During model interpretation, maternal nutritional status, offspring body weight, and developmental stage should be recorded simultaneously to distinguish direct effects of copper deficiency from secondary effects caused by maternal undernutrition or growth restriction.

3 Pharmacological Copper Depletion Models

3.1 Copper Chelator Intervention

Compounds such as D-Penicillamine and Tetrathiomolybdate can affect delivery of copper to copper-dependent proteins by binding copper or reducing exchangeable copper levels. Compared with a low-copper diet, pharmacological intervention generally takes effect more rapidly and is suitable for validating whether specific enzyme activities, metabolic pathways, or tissue phenotypes depend on copper supply. However, it may also affect other metals, redox status, or protein functions and is therefore more suitable as a mechanistic intervention or auxiliary model.

3.2 Application Boundaries of the Cuprizone Model

Cuprizone can bind copper and is widely used in mouse central nervous system research. However, the classical Cuprizone model is mainly used to induce oligodendrocyte injury and demyelination, and its pathological process involves mitochondrial injury and specific cytotoxicity. It cannot simply be regarded as equivalent to systemic nutritional copper deficiency. If the research objective is serum copper, anemia, or whole-body copper homeostasis, a low-copper diet or copper-transport-abnormality model is generally more suitable.

4 Genetic Models of Copper Deficiency

4.1 ATP7A Abnormality Models

(1) Abnormal Tissue Copper Distribution

ATP7A participates in delivery of copper to the secretory pathway and copper efflux from certain cells. When ATP7A function is abnormal, copper cannot be properly distributed among tissues even when dietary copper is available. As a result, copper may be retained in some tissues while key tissues such as the brain remain copper deficient.

(2) Reduced Function of Copper-Dependent Enzymes

ATP7A abnormalities can affect maturation of multiple copper proteins, including copper-dependent systems associated with mitochondrial energy metabolism, neurotransmitter synthesis, and connective-tissue structure. Therefore, this model is more suitable for analyzing disorders of copper transport rather than simply studying insufficient copper intake.

4.2 CTR1-Related Models

CTR1 is an important component of high-affinity cellular copper uptake. Severe systemic loss may affect embryonic or early development, so conditional or tissue-specific interventions are commonly used in experimental studies. Reducing CTR1 in the myocardium, liver, or nervous system allows direct analysis of the effects of insufficient cellular copper uptake on local copper-protein maturation, mitochondrial function, and tissue homeostasis.

5 Major Tissue Phenotypes of Copper Deficiency

5.1 Anemia and Abnormal Iron Metabolism

(1) Impaired Iron Export

Copper-containing ferroxidases such as Ceruloplasmin and Hephaestin participate in Fe²⁺ oxidation and iron export. When copper deficiency reduces the function of these proteins, tissue iron mobilization can become restricted and utilization of circulating iron can decrease.

(2) Anemia Phenotype

Copper deficiency can cause decreased hemoglobin and other hematological abnormalities, but its mechanism differs from simple iron deficiency. Some models may simultaneously show reduced circulating iron utilization and tissue iron accumulation. Therefore, hematological parameters, tissue iron, Ferritin, and related indicators should be interpreted together.

5.2 Myocardial and Mitochondrial Function

Copper deficiency can reduce the function of mitochondrial copper proteins such as Cytochrome c Oxidase, affecting electron transport, oxygen consumption, and ATP production and further inducing redox imbalance and myocardial remodeling. Heart weight and histology can reveal terminal phenotypes, whereas Complex IV activity, mitochondrial respiration, and ATP levels are more suitable for mechanistic evaluation.

5.3 Nervous System Function

(1) Mitochondrial Energy Metabolism

Neural tissues are highly dependent on oxidative phosphorylation. Copper deficiency-induced reduction in Cytochrome c Oxidase function can affect energy supply to neurons and glial cells.

(2) Neurotransmitter Metabolism

Dopamine β-Hydroxylase is a copper-dependent enzyme involved in conversion of Dopamine to Norepinephrine. Copper deficiency may alter catecholamine metabolism, causing nervous-system phenotypes to involve both energy metabolism and neurotransmitter changes.

(3) Myelination and Development

Severe or developmental copper deficiency may also affect myelination and nervous-system maturation. In perinatal models, brain copper, copper-dependent enzymes, histopathology, and behavioral results should be analyzed together.

5.4 Bone and Connective Tissue

Lysyl Oxidase depends on copper to catalyze crosslinking of collagen and elastin. Reduced function caused by copper deficiency can affect bone-matrix maturation, vascular-wall structure, and the mechanical stability of other connective tissues. Bone density, bone length, and histology can be used to evaluate overall developmental phenotypes. If a direct relationship between copper deficiency and collagen maturation needs to be established, Lysyl Oxidase activity, collagen structure, or tissue mechanical parameters should also be evaluated.

6 Evaluation and Interpretation of Copper Deficiency Models

6.1 Indicators of Copper Status

(1) Serum or Plasma Copper

Circulating copper is a basic indicator for model evaluation, but its level is affected by Ceruloplasmin, inflammation, and physiological status. Decreased serum copper can indicate altered copper status but cannot independently demonstrate that tissues have developed stable functional copper deficiency.

(2) Tissue Copper Content

The liver is an important organ for copper storage and distribution and can be used to evaluate whole-body copper reserves. Depending on the research objective, copper content in target tissues such as the brain, heart, and kidney can also be measured to determine the severity and tissue selectivity of copper deficiency.

(3) Ceruloplasmin

Ceruloplasmin reflects both copper loading and ferroxidase function. During copper deficiency, both its maturation and enzymatic activity may be affected. Therefore, combining serum copper, tissue copper, and Ceruloplasmin improves the reliability of model assessment.

6.2 Copper-Dependent Functional Indicators

(1) Ceruloplasmin and Hephaestin

Ceruloplasmin and Hephaestin both participate in copper-dependent iron oxidation, and reduced function can link copper insufficiency to impaired iron export. Measurement of related enzyme activities helps determine whether copper deficiency has progressed to functional abnormalities in metal metabolism.

(2) Cytochrome c Oxidase

Cytochrome c Oxidase is an important copper protein in the mitochondrial respiratory chain. Reduced activity can reflect the effect of insufficient copper supply on oxidative phosphorylation and is particularly suitable for evaluation in myocardial and neural tissues.

(3) Cu/Zn SOD

Cu/Zn SOD requires copper for normal catalysis. During copper deficiency, enzyme activity may decrease before obvious changes in protein expression occur. Therefore, SOD protein levels cannot directly replace evaluation of its catalytic function.

Table 2 Common Functional Indicators in Copper Deficiency Models

6.3 Iron Metabolism and Anemia Phenotypes

(1) Iron Status

Copper deficiency can affect iron export through reduced Ceruloplasmin and Hephaestin function. Therefore, Fe, Fe²⁺, Ferritin, and TIBC should be analyzed together to determine iron-storage and utilization status. Reduced circulating iron does not necessarily indicate insufficient total iron stores.

(2) Interpretation of Anemia

Hemoglobin, hematocrit, and red blood cell parameters can be used to evaluate the severity of anemia, but anemia itself is not specific to copper deficiency. Anemia can be more reliably linked to copper deficiency only when altered copper status or abnormal copper-dependent iron metabolism is also demonstrated.

6.4 Systemic and Tissue Evaluation

(1) Growth and Food Intake

Body weight, food intake, and organ weight are used to evaluate the overall status of the model. If copper deficiency markedly reduces food intake, a Pair-fed control should be considered to reduce secondary effects caused by decreased energy intake.

(2) Target-Tissue Function

Depending on the research direction, myocardial mitochondrial function, brain metabolism, skeletal structure, or connective-tissue mechanical parameters can be further evaluated. Histopathology is suitable for confirming the degree of injury but cannot independently establish a copper deficiency model.

6.5 Comprehensive Determination of Model Establishment

Stable functional copper deficiency should form a continuous evidence chain of “reduced copper supply or utilization—changes in blood or tissue copper status—reduced function of copper-dependent enzymes—abnormal target-tissue or metabolic phenotypes.” If only a mild decrease in circulating copper is observed without changes in copper-dependent functions, the condition is more appropriately interpreted as early copper depletion rather than a complete functional copper deficiency model.

7 Factors Affecting Model Stability

7.1 Mineral Composition of the Diet

(1) Zinc

High levels of zinc can affect intestinal copper absorption, so zinc levels in experimental diets should remain stable. Marked changes in zinc content may aggravate copper deficiency and increase the difficulty of mechanistic interpretation.

(2) Iron

Iron and copper metabolism are closely associated. Excessively high or low dietary iron can affect the severity of anemia and tissue iron distribution. Therefore, iron levels should be controlled as an important background variable in copper deficiency models.

(3) Molybdenum and Sulfur

Molybdenum and sulfur can affect copper bioavailability, with particularly pronounced effects in some animals, especially ruminants. Model design should distinguish low copper intake from secondary copper deficiency caused by mineral interactions.

7.2 Age and Physiological Status

Young, pregnant, and lactating animals have higher copper requirements, and the rate of model development and tissue sensitivity differ from those in adult animals. Therefore, identical modeling durations and evaluation thresholds should not be directly applied across different ages and physiological stages.

7.3 Inflammatory Status

Ceruloplasmin is an acute-phase-associated protein, and inflammation may alter its circulating level and further affect serum copper results. When obvious inflammation or tissue injury is present, tissue copper content and copper-dependent enzyme activity should also be evaluated to avoid determining model severity solely from serum copper and Ceruloplasmin.

8 Model Selection for Different Research Objectives

Table 3 Selection Criteria for Copper Deficiency Models

9 Common Questions About Copper Deficiency Models

9.1 How Should Decreased Serum Copper Without an Obvious Tissue Phenotype Be Interpreted?

This usually indicates that the model is at an early or mild stage of copper depletion. Hepatic or target-tissue copper content and copper-dependent functional indicators such as Ceruloplasmin and Cytochrome c Oxidase should be further measured rather than determining model establishment solely from serum copper.

9.2 Can Anemia Be Used as a Criterion for Successful Establishment of a Copper Deficiency Model?

No. Anemia can result from iron deficiency, inflammation, blood loss, and other nutritional abnormalities. Anemia in copper deficiency models should be accompanied by evidence of altered copper status or abnormal copper-dependent iron metabolism.

9.3 Can Decreased Ceruloplasmin Represent Copper Deficiency in All Tissues?

No. Ceruloplasmin mainly reflects circulation-related copper status. Different tissues differ in their sensitivity to copper deficiency and copper reserves. When studying mechanisms in the myocardium, brain, or liver, copper levels and functions in the corresponding tissues still need to be directly evaluated.

9.4 Does a Low-Copper Model Require a Pair-Fed Control?

When copper deficiency markedly reduces food intake and body-weight gain, a Pair-fed control helps distinguish copper-specific effects from secondary effects caused by reduced energy intake. If food intake is similar among groups, whether to include such a control can be determined according to the research objective.

9.5 Can Cuprizone Represent Nutritional Copper Deficiency?

Generally, no. The Cuprizone model is mainly used for central nervous system demyelination research, and its pathological mechanism cannot be equated with systemic copper deficiency caused by dietary copper restriction.

9.6 How Should Copper-Repletion Experiments Be Evaluated?

After copper supplementation, copper levels, copper-dependent enzyme activity, and target-tissue phenotypes should be evaluated separately. These three classes of indicators may recover at different rates, so normalization of serum copper does not mean that all copper-dependent functions have recovered.

9.7 Why Should Iron Metabolism Be Evaluated in Copper Deficiency Models?

Copper-dependent proteins such as Ceruloplasmin and Hephaestin directly participate in iron oxidation and export. Copper deficiency can cause secondary impairment of iron utilization. Therefore, indicators such as Fe, Ferritin, TIBC, and hemoglobin help explain the mechanism of anemia.

10 Products Related to Copper Deficiency Models

10.1 Model Establishment, Copper Supplementation, and Copper Status Detection

10.2 Evaluation of Copper-Dependent Functions

10.3 Evaluation of Iron Metabolism and Anemia

The key to animal models of copper deficiency is to select the corresponding model according to insufficient copper intake, impaired copper transport, or pharmacological depletion and to make a comprehensive determination by combining tissue copper levels, copper-dependent enzyme function, and target-tissue phenotypes. When anemia, myocardial injury, or nervous-system damage is involved, iron metabolism and mitochondrial function should also be evaluated to improve the accuracy of result interpretation.

For more related articles, please see below:

[1] The Technology Driving Biomedical Revolution — Animal Modeling

[2] Animal Modeling—Tumor Disease Models

[3] A Detailed Guide to the Construction of Animal Models for Metabolic Diseases

[4] Methods for Establishing Animal Models of Cardiovascular Diseases

[5] Methods for Establishing Models of Nervous System Diseases

[6] Establishment of Common Animal Disease Models and Their Experimental Methods